Abbott India appoints Prithwish K Banerji as Commercial Director - Women’s Health, Metabolics and International Business
Prithwish has close to 28 years of experience in a Commercial role
Prithwish has close to 28 years of experience in a Commercial role
He is an experienced professional in the pharmaceutical industry with about 30 years of progressive experience
DOVBLERON marks the 13th addition to Innovent’s commercial portfolio
Expects to unlock further opportunities in the Moldovan market, contributing anticipated sales of $300,000 in 2025 and approximately $700,000–$800,000 in 2026
Smeeta Bhatkal, Santosh Desai and Akshay Kumar join as Independent Directors; Shaina NC as Non-Executive Director
Both units of Shilpa Medicare (Unit IV and Unit VII), have now received GMP approval from Eurasia
Puri is an accomplished leader and financial sector veteran with over four decades of experience
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
This approval is a significant achievement in expanding the availability of this critical therapeutic,
Subscribe To Our Newsletter & Stay Updated